Reversible dementia and gait disturbance as a result of polypharmacy

BMJ Case Reports

Volumn , Issue , 2013, Pages

  Gupta, Monica ^a   Singh, Ram ^a   Singh, Kamal ^a   Lehl, S S ^a  

^a GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CARBAMAZEPINE; ESCITALOPRAM; PREGABALIN;

ADULT; AMNESIA; CASE REPORT; DEMENTIA; DIABETIC RETINOPATHY; DRUG WITHDRAWAL; GAIT DISORDER; HUMAN; HYDROCEPHALUS; LETHARGY; LUMBAR PUNCTURE; MALE; MINI MENTAL STATE EXAMINATION; MOTOR NEUROPATHY; NEUROIMAGING; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYPHARMACY; PRIORITY JOURNAL; SENSORY NEUROPATHY; WALKING DIFFICULTY;

EID: 84877283848     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2013-008932     Document Type: Note

References (3)

1. Evans MD, Shinar R, Yaari R. Reversible dementia and gait disturbance after prolonged use of valproic acid. Seizure 2011;20:509-11.
2. Zecca C, Städler C, Gobbi C. Hydrocephalus during natalizumab treatment. Neurol Sci 2010;31:635-7.
3. Maclennan A, Long MD, Herfarth HH. Development of communicating hydrocephalus after infliximab Infusion. Inflamm Bowel Dis 2011;17:E2-E3.